Form S-1/A Apimeds Pharmaceuticals
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20241209/A92ZP22DL222LJAV222P2ZY2WRBBZ222ZQ62
Filed on: December 9, 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braveheart Bio prices IPO at $18 per share, raises $382.5M
- GE HealthCare launches two breast imaging products for dense breasts
- East West Ave Acquisition Corp. closes $100M IPO on Nasdaq
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
